FDA Says OTC Asthma Inhalers with CFC Banned After Dec 31
The Food and Drug Administration states that users of epinephrine inhalers with chlorofluorocarbon (CFC)-containing epinephrine should plan now to get a prescription for a replacement product because these inhalers will not be made or sold after December 31, 2011. Primatene…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Mist, marketed by Armstrong Pharmaceutical Inc, is the only such FDA-approved over-the-counter inhaler of this type. According to FDA, this action is in accordance with the Montreal Protocol on Substances that Deplete the Ozone Layer and the phase-out date was announced in November 2008.